Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

                    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,                           ( print page 18583)                        as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; Secondary Data Analysis Review.                    

*Date:*                         May 20, 2009.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC 20037.                    

*Contact Person:*                         Nadine Rogers, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, 301-402-2105,                         *rogersn2@nida.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; Exploratory Translational Centers on Clinical Neurobiology.                    

*Date:*                         May 28, 2009.                    

*Time:*                         9 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Sofitel Washington DC Lafayette Square, 806 15th Street, NW., Washington, DC 20005.                    

*Contact Person:*                         Mark Swieter, PhD, Chief, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Suite 220, Bethesda, MD 20892-8401, (301) 435-1389,                         *ms80x@nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; Behavioral Pharmacology and Genetics: Translating and Targeting Individual Differences.                    

*Date:*                         June 4, 2009.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Omni Hotel, 2500 Calvert Street NW., Washington, DC 20037.                    

*Contact Person:*                         Scott Chen, PhD, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6101 Executive Boulevard, Room 220, MSC 8401, Bethesda, MD 20892, 301-443-9511,                         *chensc@mail.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; Centers Review.                    

*Date:*                         June 8-11, 2009.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The Fairmont, Washington, DC, 2401 M Street, NW., Washington, DC 20037.                    

*Contact Person:*                         Eliane Lazar-Wesley, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, 301-451-4530,                         *elazarwe@nida.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

*Dated:*                         April 15, 2009.                    

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-9210 Filed 4-22-09; 8:45 am]

BILLING CODE 4140-01-M